γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell

J Nutr Biochem. 2011 Dec;22(12):1127-36. doi: 10.1016/j.jnutbio.2010.09.012. Epub 2011 Feb 2.

Abstract

Antiangiogenic therapy mediated by food components is an established strategy for cancer chemoprevention. Growth factors play critical roles in tumor angiogenesis. A conditioned medium containing growth factors from human gastric adenocarcinoma SGC-7901 cell conditioned medium was used as an angiogenic stimulus in this study. The purpose of this study was to evaluate the inhibitory effect and possible mechanism of γ-tocotrienol on tumor angiogenesis. The results showed that γ-tocotrienol (10-40 μmol/L) significantly suppressed proliferation, migration and tube formation of human umbilical vein endothelial cells (HUVECs) induced by SGC-7901 cell conditioned medium in a dose-dependent manner. γ-Tocotrienol (800-1200 μg/egg) also inhibited new blood vessel formation on the growing chick embryo chorioallantoic membrane in a dose-dependent manner. Moreover, the inhibitory effects of γ-tocotrienol on HUVECs were correlated with inducing the apoptosis and arresting cell cycle at the G(0)/G(1) phase at a dose of 40 μmol/L γ-tocotrienol. In addition, γ-tocotrienol inhibited angiogenesis in HUVECs by down-regulation of β-catenin, cyclin D1, CD44, phospho-VEGFR-2 and MMP-9. The antiangiogenic effects of γ-tocotrienol on HUVECs may be attributable to regulation of Wnt signaling by decreasing β-catenin expression. Thus, our results suggest that γ-tocotrienol has a potential chemopreventive agent via antiangiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Chemoprevention
  • Chick Embryo
  • Chorioallantoic Membrane / blood supply
  • Chorioallantoic Membrane / drug effects
  • Chromans / pharmacology*
  • Chromans / therapeutic use
  • Down-Regulation
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / physiology*
  • Humans
  • Microscopy, Electron, Transmission
  • Neoplasms / blood supply
  • Neoplasms / metabolism
  • Neoplasms / prevention & control
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / pathology*
  • Neovascularization, Pathologic / prevention & control*
  • Signal Transduction
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • Vitamin E / analogs & derivatives*
  • Vitamin E / pharmacology
  • Vitamin E / therapeutic use
  • beta Catenin / genetics
  • beta Catenin / metabolism

Substances

  • Angiogenesis Inhibitors
  • Chromans
  • beta Catenin
  • Vitamin E
  • plastochromanol 8
  • Vascular Endothelial Growth Factor Receptor-2